Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline
Sertraline
Neurochemical
Serotonin reuptake inhibitor
DOI:
10.1038/s41398-018-0128-4
Publication Date:
2018-04-17T15:14:18Z
AUTHORS (12)
ABSTRACT
Abstract Cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are both effective treatments for some patients with obsessive-compulsive disorder (OCD), yet little is known about the neurochemical changes related to these treatment modalities. Here, we used positron emission tomography α-[ 11 C]methyl- l -tryptophan tracer examine in brain regional synthesis capacity OCD following CBT or SSRI treatment. Sixteen medication-free were randomly assigned 12 weeks of either sertraline Pre-to-post trapping constant, K * (ml/g/min), assessed as a function symptom response, correlations improvement examined. Responders/partial responders did not show significant relative uptake; rather, responders/partial responders, led increases that brain-wide. Irrespective modality, baseline raphe nuclei correlated positively clinical improvement. These observations suggest that, patients, successful remediation symptoms might be associated greater serotonergic tone.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (68)
CITATIONS (46)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....